Congressman Chaka Fattah Meets with Amarantus to Discuss Brain Research

Congressman Chaka Fattah Meets with Amarantus to Discuss Brain Research
amarantus-bigCongressman Chaka Fattah recently met with Amarantus, a biotechnology firm specializing in discovering and developing treatments and diagnostics for Alzheimer's disease and other degenerative brain conditions, to discuss ongoing and future neurologic research strategies. Gerald Commissiong, the CEO of Amarantus, and Robert Farrell, the CFO, had briefed Congressman Fattah on a newly-signed contract between the company and Georgetown University for 6 patent rights covering serological biomarkers for Alzheimer's disease. These rights are jointly owned by the University of Rochester and Georgetown. Congressman Fattah explained in a press release: "I continue to be impressed by the advanced research happening within the neuroscience field. This new agreement is an important milestone in Alzheimer's diagnostic development with the potential to help recognize individuals who may be at-risk for Alzheimer's and ultimately develop
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *